Hydrogen Therapy Shows Promise for Treating Bone Marrow Failure

Scientists think breathing in hydrogen gas might help treat aplastic anemia, a serious disease where your bone marrow stops making enough blood cells, because hydrogen can reduce harmful chemicals in your body and calm down the immune system that's attacking your blood cells.

This is a theoretical proposal rather than a completed study—researchers hypothesize that hydrogen therapy could treat aplastic anemia by reducing free radicals and inflammatory molecules involved in the disease, but no clinical or experimental results are presented.

Aplastic anemia is a rare and serious condition where the bone marrow fails to produce enough blood cells, leading to bleeding, infection, and organ problems. Researchers propose that hydrogen therapy might help because hydrogen can reduce harmful molecules called free radicals and lower inflammatory proteins (TNF-α and IL-6) that are thought to contribute to the disease. This paper outlines the theory behind hydrogen as a potential treatment but does not present actual study results.

While the biological reasoning is interesting, this is a hypothesis paper without actual research data. Anyone with aplastic anemia should continue working with their hematologist on established treatments. Hydrogen therapy for this condition remains entirely experimental and unproven in humans.

Aplastic anemia (AA) is a rare bone marrow failure disorder with high mortality rate, which is characterized by pancytopenia and an associated increase in the risk of hemorrhage, infection, organ dysfunction and death. The oxidation phenomenon and/or the formation of free radicals have been…

Read the full abstract on PubMed